July 24, 2009 — The US Food and Drug Administration (FDA) has approved a 0.45% ophthalmic solution of the nonsteroidal anti-inflammatory drug ketorolac tromethamine (Acuvail, Allergan, Inc) for the ...
DETROIT, Nov. 6 Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched ketorolac tromethamine ophthalmic solution, 0.5% following a final approval from the US Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . We interrupt this well-designed linear discussion of dry eye syndrome to bring you an important announcement: ...
IRVINE, Calif. — The U. S. Food and Drug Administration has approved an advanced, preservative-free formulation of ketorolac for treating pain and inflammation after cataract surgery, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback